Medimmune Limited

University of Toronto

The Hospital for Sick Children

Fundacio Privada Institut D'investigacio Oncologic

Fundacio Privada Institucio Catalana De Recerca I

Fundacio Privada Institut D'investigacio Oncologica De Vall Hebron

Fundacio Privada Institucio Catalana De Recerca I Estudis Avancats

Jean-Philippe Julien

Johan Fransson

Joan Seoane Suarez

Judit Anido Folgueira

Taylor Sicard

Anthony Semesi

Bebhinn Treanor

Edurne Rujas Diez

Swetha Raman

Tiantian Zhao

A fusion protein comprises a nanocage monomer; and an antibody or fragment thereof linked to the nanocage monomer, the antibody or fragment thereof comprising a first member of a binding pair; wherein a plurality of the fusion proteins self-assemble to form a nanocage in which a plurality of the antibodies or fragments thereof decorate the exterior surface of the nanocage, whereby the first member of the binding pair is exposed for interacting with a second member of a binding pair.

Nanoparticle platform for antibody and vaccine delivery

Described herein are antibodies that target Leukemia Inhibitory Factor (LIF). Also described herein are uses of these antibodies for the treatment of cancer.

Antibodies against LIF and uses thereof

Growing community of inventors

Toronto, Canada

Jean-Philippe Julien